CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Curiox BioSystems Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Curiox BioSystems Co Ltd
215, 121, Digital-ro, Geumcheon-gu
Phone: +82 220397160p:+82 220397160 SEOUL, 08511  South Korea Ticker: 445680445680

Business Summary
Curiox BioSystems Co Ltd is a Korea-based company primarily engaged in the manufacture and sale of automation equipment and consumables for cell analysis processes. The Company is engaged in the manufacture and sale of cell pretreatment automation devices, washing machines, plates and other products. In addition, the Company is engaged in the manufacture and sale of high-capacity adapters, strip spacers, buffer exchanger products and others.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202412/31/2023Yes----

General Information
Outstanding Shares: 16,096,738 (As of 10/2/2024)
Shareholders: 12,243
Stock Exchange: KDQ
Fax Number: +82 230167928


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024